Ferrari et al. tested 8303C human ATC cells that bore p53, BRAF, PIK3CA, and TERT mutations, whereas Tohyama et al. used RO82-W-1 human differentiated thyroid cancer cells [22,23]. Here, TP53 is linked to thyroid gland carcinoma.